1JCK image
Deposition Date 1996-10-22
Release Date 1997-11-12
Last Version Date 2024-10-23
Entry Detail
PDB ID:
1JCK
Title:
T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH SEC3 SUPERANTIGEN
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.50 Å
R-Value Free:
0.32
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:14.3.D T CELL ANTIGEN RECEPTOR
Mutations:N24Q, N74Q, N121Q
Chain IDs:A, C
Chain Length:238
Number of Molecules:2
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:STAPHYLOCOCCAL ENTEROTOXIN C3
Gene (Uniprot):entC3
Chain IDs:B, D
Chain Length:239
Number of Molecules:2
Biological Source:Staphylococcus aureus
Ligand Molecules
Primary Citation

Abstact

Superantigens (SAgs) are viral or bacterial proteins that act as potent T-cell stimulants and have been implicated in a number of human diseases, including toxic shock syndrome, diabetes mellitus and multiple sclerosis. The interaction of SAgs with the T-cell receptor (TCR) and major histocompatibility complex (MHC) proteins results in the stimulation of a disproportionately large fraction of the T-cell population. We report here the crystal structures of the beta-chain of a TCR complexed with the Staphylococcus aureus enterotoxins C2 and C3 (SEC2, SEC3). These enterotoxins, which cause both toxic shock and food poisoning, bind in an identical way to the TCR beta-chain. The complementarity-determining region 2 (CDR2) of the beta-chain and, to lesser extents, CDR1 and hypervariable region 4 (HV4), bind in a cleft between the two domains of the SAgs. Thus, there is considerable overlap between the SAg-binding site and the peptide/MHC-binding sites of the TCR. A model of a TCR-SAg-MHC complex constructed from the crystal structures of (1) the beta-chain-SEC3 complex, (2) a complex between staphylococcal enterotoxin B (SEB) and an MHC molecule, and (3) a TCR V(alpha) domain, reveals that the SAg acts as a wedge between the TCR and MHC to displace the antigenic peptide away from the TCR combining site. In this way, the SAg is able to circumvent the normal mechanism for T-cell activation by specific peptide/MHC complexes.

Legend

Protein

Chemical

Disease

Primary Citation of related structures